Anpac Bio Medical Stock Earnings Per Share
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Anpac Bio Medical fundamentals help investors to digest information that contributes to Anpac Bio's financial success or failures. It also enables traders to predict the movement of Anpac Stock. The fundamental analysis module provides a way to measure Anpac Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anpac Bio stock.
Anpac |
Anpac Bio Medical Company Earnings Per Share Analysis
Anpac Bio's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Anpac Bio Earnings Per Share | (11.45) X |
Most of Anpac Bio's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anpac Bio Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Anpac Bio Medical has an Earnings Per Share of -11.45 times. This is 236.8% lower than that of the Healthcare sector and 139.04% higher than that of the Biotechnology industry. The earnings per share for all United States stocks is notably higher than that of the company.
Anpac Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anpac Bio's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics of similar companies.Anpac Bio is currently under evaluation in earnings per share category among its peers.
Anpac Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.53 | |||
| Operating Margin | (8.71) % | |||
| Current Valuation | 9.28 M | |||
| Shares Outstanding | 6.27 M | |||
| Shares Owned By Insiders | 2.15 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Number Of Shares Shorted | 44.48 K | |||
| Price To Book | 5.67 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 12.04 M | |||
| Gross Profit | 12.25 M | |||
| EBITDA | (78.4 M) | |||
| Net Income | (103.6 M) | |||
| Cash And Equivalents | 462 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 19.81 M | |||
| Debt To Equity | 1.44 % | |||
| Current Ratio | 0.39 X | |||
| Book Value Per Share | 10.63 X | |||
| Cash Flow From Operations | (55.06 M) | |||
| Short Ratio | 2.50 X | |||
| Earnings Per Share | (11.45) X | |||
| Target Price | 8.0 | |||
| Beta | 1.56 | |||
| Market Capitalization | 27.41 M | |||
| Total Asset | 40.47 M | |||
| Retained Earnings | (577.54 M) | |||
| Working Capital | (28.58 M) | |||
| Current Asset | 23.44 M | |||
| Current Liabilities | 68.22 M | |||
| Z Score | -26.09 | |||
| Net Asset | 40.47 M |
About Anpac Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anpac Bio Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |